This is a working overview of reference standard, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2026-08-01. Anything still debated is marked as such rather than presented as settled.
Routine characterization of the peptide relies on reversed-phase high-performance liquid chromatography for purity assessment, usually with ultraviolet detection near 214 nanometers. Intact mass measurement by liquid chromatography coupled to mass spectrometry confirms molecular identity against a theoretical value. Sequence-level confirmation uses enzymatic digestion followed by tandem mass spectrometry, an approach known as peptide mapping. Amino acid analysis gives an independent check on composition. Circular dichroism spectra are used to estimate helical content in aqueous buffer.
Stability depends strongly on physical form. The dry powder is generally regarded as stable for extended periods when held at or below minus twenty degrees Celsius in a sealed, desiccated container. In solution, degradation pathways include deamidation of asparagine and glutamine residues, oxidation of methionine, and aggregation. Reaction rates for these pathways rise with temperature. Repeated freezing and thawing of solutions promotes aggregation, and light exposure can accelerate some oxidative changes. Buffer composition and pH influence which pathway dominates at a given temperature.
Characterization of the peptide relies on reversed-phase high-performance liquid chromatography for purity and related-substance profiling, with ultraviolet detection near 214 nanometers. Mass spectrometry confirms molecular mass and reveals modifications such as oxidation or deamidation. Peptide mapping after enzymatic digestion verifies the amino acid sequence, while amino acid analysis supplies compositional data. Circular dichroism and infrared spectroscopy are used to assess secondary structure, particularly the alpha-helical content that influences aggregation behavior in solution.
Common degradation routes include hydrolysis of labile amide bonds, deamidation of asparagine and glutamine residues, oxidation of methionine and tryptophan, and non-covalent aggregation. Aggregates can form during freeze-thaw cycling, at elevated pH, or when peptide concentration is high. Each route produces characteristic chromatographic or mass shifts that are tracked during stability studies. Whether a given minor impurity alters biological activity is often an open question, and specification limits are typically set on identity and purity rather than on functional data for trace species.
| Property | Value | Notes |
|---|---|---|
| Primary purity method | Reversed-phase HPLC | Ultraviolet detection near 214 nm |
| Identity confirmation | Intact mass by LC-MS | Compared with theoretical average mass |
| Sequence verification | Enzymatic peptide mapping | Tandem mass spectrometry of fragments |
| Common degradation route | Deamidation and oxidation | Rate increases with pH and temperature |
| Reference material | Lyophilized peptide standard | Stored desiccated below -20 °C |
Tirzepatide activates both the glucose-dependent insulinotropic polypeptide receptor and the glucagon-like peptide-1 receptor, making it a dual agonist rather than a selective agent. Engagement of the GLP-1 receptor is linked to glucose-dependent insulin release, slower gastric emptying, and reduced appetite signalling. The relative contribution of the GIP arm remains an active research question; proposed roles include improved insulin sensitivity and altered adipose tissue handling. Receptor occupancy studies suggest the molecule interacts with both targets at circulating concentrations achieved during therapy.
Development began in the 2010s, when researchers modified a GIP-based scaffold to add GLP-1 activity and then attached the fatty diacid to lengthen its half-life. Clinical evaluation proceeded through large phase 3 programmes in type 2 diabetes and in obesity, and regulators in the United States cleared the compound for type 2 diabetes in 2022 and for chronic weight management in 2023. Several cardiovascular and metabolic outcome studies are still reporting, so the picture of long-term benefit and risk is incomplete. Approvals in other regions followed on different timelines.
Tirzepatide is a synthetic linear peptide of 39 amino acids that acts as a dual agonist at the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. Its sequence derives from native GIP but incorporates non-natural residues and a C20 fatty diacid moiety linked to a lysine side chain. The lipophilic chain promotes albumin binding, which slows renal clearance and extends circulation time. The unmodified peptide has a molecular formula of C225H348N48O68 and a molecular mass near 4,813 daltons.
Receptor activation by tirzepatide raises intracellular cyclic AMP through Gs-coupled signalling at both targets. At the GLP-1 receptor the downstream effect includes glucose-dependent insulin release, suppressed glucagon secretion, delayed gastric emptying, and reduced appetite signalling in the hypothalamus. GIP receptor engagement adds insulinotropic activity and appears to influence lipid handling in adipose tissue. Because both receptors are stimulated at the same time, the pharmacological profile differs from that of selective GLP-1 receptor agonists, and the relative contribution of each arm remains an area of active investigation.
Clinical development proceeded through large phase 3 programmes in type 2 diabetes and in obesity or overweight with at least one weight-related comorbidity. Regulatory approvals followed in several jurisdictions for both indications. Weekly subcutaneous dosing reflects an elimination half-life of roughly five days. Open questions include the durability of metabolic effects after treatment stops, long-term cardiovascular and hepatic outcomes beyond completed trials, and whether the dual mechanism confers benefits independent of total receptor occupancy. Published literature continues to expand on these points. Substantial uncertainty remains about interindividual variability in response.
=== Comparison with actions of other PDE5 inhibitors === Sildenafil and vardenafil inhibit PDE6, an enzyme found in the eye, more than tadalafil. Some sildenafil users see a bluish tinge and have a heightened sensitivity to light because of PDE6 inhibition. Sildenafil and vardenafil also inhibit PDE1 more than tadalafil. PDE1 is found in the brain, heart, and vascular smooth muscle. It is thought that the inhibition of PDE1 by sildenafil and vardenafil leads to vasodilation, flushing, and tachycardia. Tadalafil inhibits PDE11 more than sildenafil or vardenafil. PDE11 is expressed in skeletal muscle, the prostate, the liver, the kidney, the pituitary gland, and the testes. The effects on the body of inhibiting PDE11 are not known.
== Name == Cold noodles in Chinese cuisine are referred to as liángmiàn (凉面, "chilled noodles"). The term lěngmiàn (冷面, "cold noodles") is mainly associated with Korean-style cold noodles (naengmyeon), which are popular in Northeast China, especially the Yanji-style cold noodles (延吉冷面), a dish of the ethnic Korean communities of the region. Although kǎolěngmiàn contains the word lěngmiàn, the dish is not directly derived from Korean cold noodles. Rather, it developed in Northeast China from starch noodle sheets used in the production of Korean-style cold noodles in the region. As these sheets began to be mass-produced and sold cheaply, street vendors used them to create a grilled snack cooked on charcoal stoves or iron griddles. Vendors commonly market the dish under names such as "Northeast grilled cold noodles" (东北烤冷面), "Heilongjiang grilled cold noodles" (黑龙江烤冷面), and sometimes "Harbin grilled cold noodles" (哈尔滨烤冷面), despite the dish not having originated in Harbin. It is also sometimes marketed as "Korean grilled cold noodles" (朝鲜烤冷面 / 韩国烤冷面) because of its association with Korean-style cold noodles (lěngmiàn) in the name, even though grilled cold noodles themselves did not originate in Korea.
=== Main characters === Frank Poole: 3001's protagonist, Frank Poole has been revived by highly advanced medicine, a thousand years after being killed by HAL during the Discovery's original mission. Dr. Indra Wallace: A specialist on the history of the early twenty-first century, Wallace acts as Poole's cultural guide. Halman: a merging of the entities that were once HAL 9000 and Dave Bowman, Halman communicates with Poole at various points throughout the novel, warning Poole of the possibility that the monoliths may issue negative judgment against humanity.
Sources: en.wikipedia.org
=== Crowding of the border === After hearing the 9 November broadcast, East Germans began gathering at the Wall, at the six checkpoints between East and West Berlin, demanding that border guards immediately open the gates. The surprised and overwhelmed guards made many hectic telephone calls to their superiors about the problem. At first, they were ordered to find the "more aggressive" people gathered at the gates and stamp their passports with a special stamp that barred them from returning to East Germany—in effect, revoking their citizenship. However, this still left thousands of people demanding to be let through "as Schabowski said we can". It soon became clear that no one among the East German authorities would take personal responsibility for issuing orders to use lethal force, so the vastly outnumbered soldiers had no way to hold back the huge crowd of East German citizens. Mary Elise Sarotte in a 2009 Washington Post story characterized the series of events leading to the fall of the Wall as an accident, saying "One of the most momentous events of the past century was, in fact, an accident, a semicomical and bureaucratic mistake that owes as much to the Western media as to the tides of history".
=== G-Man === The G-Man (voiced by Michael Shapiro) is a mysterious recurring character. He is known to display peculiar behavior, and capabilities beyond that of an ordinary human. His identity and motives remain almost entirely unexplained. He plays the role of an overseer and employer, both observing the player as the games progress and pulling strings to control the outcome of specific events throughout the Half-Life saga. The G-Man's constant appearances in the Half-Life games, as well as his revealing monologues with series protagonist Gordon Freeman, imply that he is of great importance and somewhat anchors the efforts of the player. His mysterious nature has made him an icon of the Half-Life series. During the development of Half-Life, after the designers discovered the usefulness of allied NPCs, the development team began to cast for characters who were "neither allies nor outright enemies, but existed mainly to create a sense of intrigue", which eventually led to the creation of the G-Man. According to Half-Life writer Marc Laidlaw, G-Man was inspired by the character Slowslop in Synergy's computer game Gadget: Invention, Travel, & Adventure (1993), which Laidlaw had adapted into a novel in 1996.
=== Effect of Stimuli on the Release of TSH === Multiple neurogenic stimuli are known to affect the release of TSH from thyrotropes. Exposure to cold temperatures increases the secretion of TSH. This increased secretion results from the increased secretion of TRH, as the hypothalamus is excited by the change in body temperature. Furthermore, emotions that activate the sympathetic nervous system—such as excitement and anxiety—decrease the secretion of TSH. The decrease in secretion is also connected to the change in body temperature. Activation of the sympathetic nervous system increases the body temperature, which then causes a decrease in TRH secretion and the subsequent decrease in TSH secretion. Thyroid hormones can have a direct inhibitory effect on thyrotropic cells, though the exact mechanism is unknown. At elevated levels of thyroxine, the rate of secretion of TSH decreases to near zero, as the body tries to maintain a relatively constant level of thyroid hormone in circulation. However, the inhibitory effect of thyroid hormones may decrease in thyrotropic tumor cells. The receptor affinity for T3 significantly decreases for thyrotropic tumor cells in culture when compared to healthy thyrotropes, which reduces the regulatory effect. In addition, during pregnancy, the size of the pituitary gland increases, and consequently, the expression of TSH also increases. This increase in secretion of TSH likely results from the additional metabolic load that pregnant mothers experience in combination with the secretion of placental hormones.
== See also == Market capitalization § Market cap terms, including large-cap and mid-cap Small-cap Microcap stock, including nano-caps List of public corporations by market capitalization Magnificent Seven (stocks) Market price Authorised capital Treasury stock
Sources: en.wikipedia.org
Peptide mapping with tandem mass spectrometry is the standard approach. The peptide is digested with an enzyme such as trypsin, and the resulting fragments are matched against the expected sequence.
Higher pH and elevated temperature both increase deamidation rates. Holding solutions at low temperature and near-neutral to slightly acidic pH reduces the extent of the reaction.
Removing water slows hydrolysis and aggregation. The dry powder tolerates longer storage intervals than a solution kept at the same temperature.
Reversed-phase high-performance liquid chromatography is the standard approach, separating the main peak from related impurities. Ultraviolet detection near 214 nanometers captures the peptide backbone. Mass spectrometry is then used alongside chromatography to confirm identity and detect covalent modifications.